ARS Pharmaceuticals, Inc. (SPRY) stock
SPRYNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.89+0.08 (+2.10%)
Close on Nov 13, 2026Market cap $386.85MP/E –Yield –
ARS Pharmaceuticals enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
ARS Pharmaceuticals's enterprise value was $248.93M on Nov 11, 2026, against $654.76M a year earlier. Over the last 5 years it ranged from -$130.38M to $1.46B, with a median of $552.32M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $248.93M | -71.2% |
| 2025 | Dec 31, 2025 | $863.33M | +5.2% |
| 2024 | Dec 31, 2024 | $820.28M | +189.8% |
| 2023 | Dec 29, 2023 | $283.06M | +37.8% |
| 2022 | Dec 30, 2022 | $205.36M | – |
| 2021 | Dec 31, 2021 | -$67.66M | – |
See a number that looks wrong?